Back
Phathom Pharmaceuticals Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Buy
69
PHAT
Phathom Pharmaceuticals
Last Price:
9.49
Seasonality Move:
9.3%
Sell
44
LIXT
Lixte Biotechnology Holdings
Last Price:
3.35
Seasonality Move:
8.17%
Buy
69
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $9.52. The Score for PHAT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $3.35. The Score for LIXT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $9.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $3.35
The current trend is moderately bullish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 44.91 | Sell |
Chaikin Money Flow: | -231576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.03 - 11.15) | Sell |
Bollinger Bands (100): | (7.32 - 10.14) | Buy |
LIXT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 57.13 | Buy |
Chaikin Money Flow: | -18268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.46 - 3.56) | Buy |
Bollinger Bands (100): | (1.99 - 2.95) | Buy |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.49 | Sell |
20-day SMA: | 10.5 | Sell |
50-day SMA: | 9.49 | Buy |
200-day SMA: | 10.29 | Sell |
8-day EMA: | 10.16 | Sell |
20-day EMA: | 10.19 | Sell |
50-day EMA: | 9.64 | Sell |
200-day EMA: | 9.75 | Sell |
LIXT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.38 | Sell |
20-day SMA: | 3.19 | Buy |
50-day SMA: | 2.74 | Buy |
200-day SMA: | 2.72 | Buy |
8-day EMA: | 3.37 | Sell |
20-day EMA: | 3.19 | Buy |
50-day EMA: | 2.85 | Buy |
200-day EMA: | 3.28 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.75 per share, and an increase next year of $1.24 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Technical Analysis
Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lixte Biotechnology Holdings Technical Analysis
Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |